These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32130328)

  • 1. OM-85 BV for primary prevention of recurrent airway infections: a pilot randomized, double-blind, placebo-controlled study.
    Souza FC; Mocellin M; Ongaratto R; Leitão LAA; Friedrich FO; Silveira VD; Scotta MC; Pitrez PM; Pinto LA
    Einstein (Sao Paulo); 2020; 18():eAO5262. PubMed ID: 32130328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunostimulant OM-85 BV prevents wheezing attacks in preschool children.
    Razi CH; Harmancı K; Abacı A; Özdemir O; Hızlı S; Renda R; Keskin F
    J Allergy Clin Immunol; 2010 Oct; 126(4):763-9. PubMed ID: 20920766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of two courses of OM-85 BV in the prevention of respiratory tract infections in children during 12 months.
    Gutiérrez-Tarango MD; Berber A
    Chest; 2001 Jun; 119(6):1742-8. PubMed ID: 11399700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of OM-85 BV in children suffering from recurrent respiratory tract infections and subnormal IgG subclass levels.
    Del-Río-Navarro BE; Luis Sienra-Monge JJ; Berber A; Torres-Alcántara S; Avila-Castañón L; Gómez-Barreto D
    Allergol Immunopathol (Madr); 2003; 31(1):7-13. PubMed ID: 12573204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary prevention of acute respiratory tract infections in children using a bacterial immunostimulant: a double-masked, placebo-controlled clinical trial.
    Jara-Pérez JV; Berber A
    Clin Ther; 2000 Jun; 22(6):748-59. PubMed ID: 10929921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of OM-85 BV on hBD-1 and immunoglobulin in children with asthma and recurrent respiratory tract infection].
    Liao JY; Zhang T
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 May; 16(5):508-12. PubMed ID: 24857002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, placebo-controlled, double-blinded, single-centre, phase IV trial to assess the efficacy and safety of OM-85 in children suffering from recurrent respiratory tract infections.
    Esposito S; Bianchini S; Bosis S; Tagliabue C; Coro I; Argentiero A; Principi N
    J Transl Med; 2019 Aug; 17(1):284. PubMed ID: 31443716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Safety and efficacy of OM-85-BV plus amoxicillin/clavulanate in the treatment of subacute sinusitis and the prevention of recurrent infections in children].
    Gómez Barreto D; De la Torre C; Alvarez A; Faure A; Berber A
    Allergol Immunopathol (Madr); 1998; 26(1):17-22. PubMed ID: 9585823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OM-85 BV: primary versus secondary prevention.
    Collet JP; Boissel JP
    Respiration; 1994; 61 Suppl 1():20-3. PubMed ID: 7800967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunostimulation with OM-85 in children with recurrent infections of the upper respiratory tract: a double-blind, placebo-controlled multicenter study.
    Schaad UB; Mütterlein R; Goffin H;
    Chest; 2002 Dec; 122(6):2042-9. PubMed ID: 12475845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review.
    Schaad UB
    World J Pediatr; 2010 Feb; 6(1):5-12. PubMed ID: 20143206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of OM-85 Given during Two Consecutive Years to Children with a History of Recurrent Respiratory Tract Infections: A Retrospective Study.
    Esposito S; Bianchini S; Polinori I; Principi N
    Int J Environ Res Public Health; 2019 Mar; 16(6):. PubMed ID: 30934539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy with an oral bacterial extract (OM-85 BV) for upper respiratory infections.
    Paupe J
    Respiration; 1991; 58(3-4):150-4. PubMed ID: 1745846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pidotimod for the prevention of acute respiratory infections in healthy children entering into daycare: A double blind randomized placebo-controlled study.
    Mameli C; Pasinato A; Picca M; Bedogni G; Pisanelli S; Zuccotti GV;
    Pharmacol Res; 2015 Jul; 97():79-83. PubMed ID: 25931316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of OM-85 BV for the prevention of acute respiratory tract infections in occupational medicine.
    Carmona-Ramírez MA; Alvárez-Gómez V; Berber A
    J Int Med Res; 2002; 30(3):325-9. PubMed ID: 12166352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immunostimulant.
    Collet JP; Shapiro P; Ernst P; Renzi T; Ducruet T; Robinson A
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1719-24. PubMed ID: 9412546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a mixed bacterial lysate (OM-85 BV) on the immunogenicity, safety and tolerability of inactivated influenza vaccine in children with recurrent respiratory tract infection.
    Esposito S; Marchisio P; Prada E; Daleno C; Porretti L; Carsetti R; Bosco A; Ierardi V; Scala A; Principi N
    Vaccine; 2014 May; 32(22):2546-52. PubMed ID: 24681270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with OM-85 BV in upper and lower respiratory tract infections.
    Derenne JP; Delclaux B
    Respiration; 1992; 59 Suppl 3():28-31. PubMed ID: 1439237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind study of OM-85 in patients with chronic bronchitis or mild chronic obstructive pulmonary disease.
    Solèr M; Mütterlein R; Cozma G;
    Respiration; 2007; 74(1):26-32. PubMed ID: 16772707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bifidobacterium animalis subsp. lactis in prevention of common infections in healthy children attending day care centers - Randomized, double blind, placebo-controlled study.
    Hojsak I; Močić Pavić A; Kos T; Dumančić J; Kolaček S
    Clin Nutr; 2016 Jun; 35(3):587-91. PubMed ID: 26031908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.